Collectively, these results suggest that EpAb2-6 may induce cancer cell cytotoxic activity by inducing an apoptosis pathway, and that EpAb2-6 inhibits EpICD nuclear translocation by blocking the cleavage of EpCAM. Here, EPCAM is linked to cancer.